Skip to main content

Inspection visit

Health inspection

POLO REHABILITATION & HCCCMS #1457271 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review the facility failed to ensure a resident received the physician ordered dosage of medication after an order change which applies to 1 of 4 residents (R2) reviewed for pharmacy services in a sample of 4. The finding include: R2's Facility assessment dated [DATE] showed R2 is a [AGE] year old male resident admitted to the facility on [DATE] with diagnoses which includes depression. R2's discontinued Physician Order sheet printed on 9/16/24 showed R2's Doxepin 10 milligrams (mg) order was changed to Doxepin 5 mg on 3/14/24. No other modifications to R2's Doxepin orders were made until 9/12/24. This form showed R2's Doxepin order was changed from 5 mg to 10 mg on 9/12/24. R2's Progress notes dated 3/14/24 showed R2's physician gave a new order to reduce Doxepin to 5 mg. The facility could use the last of the 10 mg doses until the Veterans Affairs (VA) pharmacy could change the medication which could take up to 10 business days. Progress notes dated 3/15/24 showed the pharmacy requested a new order for Doxepin. Doxepin does not come in 5 mg capsules. Doxepin only comes in 3 mg, 6 mg, or 10 mg capsules. Progress Notes dated 4/29/24 showed the VA pharmacy needed a revised script for Doxepin 5 mg to be given in an elixir form. On 9/17/24 at 11:45 AM, V9 Pharmacy Clinical Manager stated Doxepin does not come in a 5 mg dose. It comes in 3 mg and 6 mg tablets and 10 mg, 25 mg and 50 mg capsules. If it needed to be a 5 mg dose it can be made into a 10 mg per milliliter (ml) elixir (suspension). Which could be given at 0.5 ml for the 5 mg dose. On 9/16/24 at 11:30 AM, V4 Registered Nurse (RN) removed R2's Doxepin bottle from the medication cart and one from storage. Both bottles showed Doxepin 10 mg capsules. V4 stated the medication comes in capsules which could not be cut in half like a tablet. V4 stated if a medication and order do not match we need to contact the physician to verify the order, and possibly hold the dose until we get the correct medication. V4 stated R2's Doxepin has always come in 10 mg capsules. V4 stated R4 has never had a liquid version of Doxepin. On 9/16/24 at 12:35 PM, V5 Licensed Practical Nurse stated R2 has always had 10 mg capsule for his Doxepin dose. V5 stated if a medication does not match the order the physician an pharmacy need to be notified so the order can be verified, and the medication can be changed to the correct dose if needed. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 145727 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145727 B. Wing A. Building (X3) DATE SURVEY COMPLETED 09/17/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Polo Rehabilitation & Hcc 703 East Buffalo Polo, IL 61064 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few R2's undated VA medication list showed R2 received Doxepin 10 milligram (mg) capsules with a last refill date of 7/10/24. On 9/16/24 at 11:45 AM, V2 Director of Nursing stated if a medication order and the medication do not match the physician needs to be contacted to verify the order. The pharmacy also needs to be contacted. In this case the VA provides R2's medications which should have been followed through with for the medication change. V2 stated she was not sure why the when the order changed the medication was not followed up on. The facility's Medication Pass Policy dated 5/2019 showed the five rights for medications administration which includes: verifying the drug against the eMAR (electronic medication administration record) ensuring the label matches the eMAR exactly, and verify the dose in each blister (container) against the eMAR. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145727 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

FAQ · About this visit

Common questions about this visit

What happened during the September 17, 2024 survey of POLO REHABILITATION & HCC?

This was a inspection survey of POLO REHABILITATION & HCC on September 17, 2024. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at POLO REHABILITATION & HCC on September 17, 2024?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.